- Rapid oxidation of histamine H2-receptor antagonists by peroxymonosulfate during water treatment: Kinetics, products, and toxicity evaluation
-
Peroxymonosulfate (PMS) is an appealing oxidant for organic contaminant destruction relying on radical generation after activation. Herein, we report PMS-promoted rapid degradation of histamine H2-receptor antagonists (HRAs) through non-radical process for the first time. Five commonly used HRAs, i.e., ranitidine (RNTD), cimetidine (CMTD), famotidine (FMTD), nizatidine (NZTD) and roxatidine (RXTD), were examined their reactivity towards PMS. Results show that HRAs (except RXTD) exhibit high reactivity towards PMS, with apparent second-order rate constants from 403 to 872 M?1s?1 at pH 7.0. Radical scavenging experiments excluded the contribution of radicals to PMS-promoted degradation of HRAs, and this non-radical process was unaffected by the real water matrices. Structure-activity assessment and theoretical calculation indicated that the thioether sulfur in HRAs (except RXTD) was the main reactive site for PMS oxidation. Transformation product analysis further elucidated oxidation of the thioether sulfur to sulfoxide product through an oxygen atom transfer process. Moreover, the thioether sulfur on the straight chain was more susceptible to oxygen transfer with PMS than that on the thiazole ring of HRAs. Toxicity evaluation indicated the ecotoxicity of HRAs could be remarkably reduced after PMS oxidation. Hence, this work provides a promising strategy to rapidly remove HRAs and significantly reduce their toxicity in water treatment.
- Chen, Jiabin,Gao, Pin,Huang, Jinjing,Liu, Tongcai,Liu, Xiang,Qian, Yajie,Xue, Gang,Zhang, Yalei,Zhou, Xuefei
-
-
Read Online
- Kinetics of ranitidine metabolism in dog and rat isolated hepatocytes
-
Freshly isolated hepatocytes from rat and dog have been evaluated as a model for the metabolism of ranitidine in vivo. Isolated hepatocytes from the male and female dog and male Wistar and random hooded rat metabolized ranitidine to ranitidine N-oxide, ranitidine S-oxide, desmethyl-ranitidine and two unidentified minor metabolites. The furoic acid metabolite of ranitidine, previously reported to be a minor metabolite in vivo in rat and dog, was not detected in hepatocytes from either species. The kinetics for ranitidine metabolism in hepatocytes were monophasic for the formation of the three major metabolites in dog and Wistar rat and for N-demethylation of ranitidine in the random hooded rat, but biphasic in this latter strain for the N- and S-oxidation of ranitidine. Ranitidine N-oxide was reduced to ranitidine by Wistar rat hepatocytes but not by hepatocytes from the random hooded rat or dog. Ranitidine S-oxide was metabolized by hepatocytes from both species to one of the unidentified metabolites but was not reduced to ranitidine in either species. Desmethylranitidine was not a substrate for metabolism in hepatocytes from either species. The relative quantitative importance of ranitidine N-oxide, ranitidine S-oxide and desmethylranitidine produced by the hepatocytes was consistent with the profiles of these three metabolites in vivo in rat and dog. The results confirm the value of isolated hepatocytes as a predictive model for in vivo drug metabolism.
- Cross,Bell,Wilson
-
p. 367 - 375
(2007/10/03)
-
